S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
S&P 500   3,811.15
DOW   30,932.37
QQQ   314.14
Log in

Ekso Bionics Stock Forecast, Price & News

-0.01 (-0.14 %)
(As of 02/26/2021 12:00 AM ET)
Today's Range
Now: $7.15
50-Day Range
MA: $9.13
52-Week Range
Now: $7.15
Volume398,813 shs
Average Volume535,572 shs
Market Capitalization$87.37 million
P/E RatioN/A
Dividend YieldN/A
Ekso Bionics Holdings, Inc. designs, develops, and sells exoskeletons for use in the healthcare, industrial, and military markets in the United States and internationally. The company operates in two segments, EksoHealth and EksoWorks. It primarily offers EksoNR, a bionic suit that provides the ability to stand and walk over ground with a full weight-bearing, reciprocal gait using a cane, crutches, or a walker to individuals with spinal cord injuries and hemiplegia due to stroke; and EksoUE, a wearable assistive device that helps to reduce the effect of gravity on the wearer's shoulders and arms, as well as reduce fatigue while rehabilitation sessions to achieve a larger active range of motion. The company's Ekso devices are primarily used in a hospital and rehabilitation setting. It has a license agreement with Lockheed Martin Corporation, Regents of the University of California, and Garrett Brown, as well as with OttoBock Healthcare Products Gmbh. The company was founded in 2005 and is headquartered in Richmond, California.
Ekso Bionics logo

Industry, Sector and Symbol

Industry General industrial machinery,
Current SymbolNASDAQ:EKSO
Previous SymbolOTCMKTS:EKSOD
Year FoundedN/A



Sales & Book Value

Annual Sales$13.92 million
Book Value$1.17 per share


Net Income$-12,130,000.00
Net Margins-140.82%


Market Cap$87.37 million
Next Earnings Date4/29/2021 (Estimated)
OptionableNot Optionable


Overall MarketRank

1.37 out of 5 stars

Medical Sector

620th out of 1,960 stocks

General Industrial Machinery, Industry

4th out of 11 stocks

Analyst Opinion: 3.5Community Rank: 2.7Dividend Strength: 0.0Insider Behavior: 0.0Valuation: 0.6 5 -4 -3 -2 -1 -
-0.01 (-0.14 %)
(As of 02/26/2021 12:00 AM ET)
30 days | 90 days | 365 days | Advanced Chart

Receive EKSO News and Ratings via Email

Sign-up to receive the latest news and ratings for EKSO and its competitors with MarketBeat's FREE daily newsletter.

speech bubbles
speech bubbles

Ekso Bionics (NASDAQ:EKSO) Frequently Asked Questions

Is Ekso Bionics a buy right now?

3 Wall Street analysts have issued "buy," "hold," and "sell" ratings for Ekso Bionics in the last year. There are currently 3 buy ratings for the stock. The consensus among Wall Street analysts is that investors should "buy" Ekso Bionics stock.
View analyst ratings for Ekso Bionics
or view top-rated stocks.

What stocks does MarketBeat like better than Ekso Bionics?

Wall Street analysts have given Ekso Bionics a "Buy" rating, but there may be better short-term opportunities in the market. Some of MarketBeat's past winning trading ideas have resulted in 5-15% weekly gains. MarketBeat just released five new trading ideas, but Ekso Bionics wasn't one of them. MarketBeat thinks these five stocks may be even better buys.
View MarketBeat's top stock picks here.

Are investors shorting Ekso Bionics?

Ekso Bionics saw a increase in short interest during the month of January. As of January 15th, there was short interest totaling 247,000 shares, an increase of 31.4% from the December 31st total of 188,000 shares. Based on an average daily trading volume, of 168,900 shares, the short-interest ratio is presently 1.5 days. Approximately 3.3% of the company's shares are short sold.
View Ekso Bionics' Short Interest

When is Ekso Bionics' next earnings date?

Ekso Bionics is scheduled to release its next quarterly earnings announcement on Thursday, April 29th 2021.
View our earnings forecast for Ekso Bionics

How were Ekso Bionics' earnings last quarter?

Ekso Bionics Holdings, Inc. (NASDAQ:EKSO) issued its quarterly earnings results on Thursday, February, 25th. The company reported ($0.48) earnings per share for the quarter, missing the consensus estimate of ($0.30) by $0.18. Ekso Bionics had a negative trailing twelve-month return on equity of 201.69% and a negative net margin of 140.82%.
View Ekso Bionics' earnings history

How has Ekso Bionics' stock been impacted by Coronavirus?

Ekso Bionics' stock was trading at $0.2616 on March 11th, 2020 when Coronavirus reached pandemic status according to the World Health Organization. Since then, EKSO shares have increased by 2,633.2% and is now trading at $7.15.
View which stocks have been most impacted by COVID-19

When did Ekso Bionics' stock split? How did Ekso Bionics' stock split work?

Shares of Ekso Bionics reverse split on the morning of Thursday, May 5th 2016. The 1-7 reverse split was announced on Wednesday, May 4th 2016. The number of shares owned by shareholders was adjusted after the market closes on Wednesday, May 4th 2016. An investor that had 100 shares of Ekso Bionics stock prior to the reverse split would have 14 shares after the split.

What guidance has Ekso Bionics issued on next quarter's earnings?

Ekso Bionics updated its fourth quarter 2020 After-Hours earnings guidance on Wednesday, January, 13th. The company provided EPS guidance of for the period. The company issued revenue guidance of $2.3-2.3 million, compared to the consensus revenue estimate of $2.58 million.

What price target have analysts set for EKSO?

3 brokerages have issued twelve-month target prices for Ekso Bionics' shares. Their forecasts range from $8.00 to $11.00. On average, they anticipate Ekso Bionics' share price to reach $9.33 in the next twelve months. This suggests a possible upside of 30.5% from the stock's current price.
View analysts' price targets for Ekso Bionics
or view top-rated stocks among Wall Street analysts.

Who are Ekso Bionics' key executives?

Ekso Bionics' management team includes the following people:
  • Mr. Steven A. Sherman, Exec. Chairman (Age 75, Pay $100k)
  • Mr. Jack Peurach, Pres, CEO & Director (Age 55, Pay $275k)
  • Mr. John F. Glenn, CFO & Sec. (Age 59, Pay $281.02k)
  • Mr. William R. Shaw, Chief Commercial Officer (Age 47)
  • Ms. Foon Lim Chwee, Pres of APAC
  • Mr. Matthias Stief, Managing Director of Ekso Bionics Europe GmbH

Who are some of Ekso Bionics' key competitors?

What other stocks do shareholders of Ekso Bionics own?

What is Ekso Bionics' stock symbol?

Ekso Bionics trades on the NASDAQ under the ticker symbol "EKSO."

Who are Ekso Bionics' major shareholders?

Ekso Bionics' stock is owned by a number of retail and institutional investors. Top institutional shareholders include Virtu Financial LLC (0.09%).
View institutional ownership trends for Ekso Bionics

Which institutional investors are buying Ekso Bionics stock?

EKSO stock was bought by a variety of institutional investors in the last quarter, including Virtu Financial LLC.
View insider buying and selling activity for Ekso Bionics
or or view top insider-buying stocks.

How do I buy shares of Ekso Bionics?

Shares of EKSO can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

What is Ekso Bionics' stock price today?

One share of EKSO stock can currently be purchased for approximately $7.15.

How much money does Ekso Bionics make?

Ekso Bionics has a market capitalization of $87.37 million and generates $13.92 million in revenue each year. The company earns $-12,130,000.00 in net income (profit) each year or ($3.45) on an earnings per share basis.

How many employees does Ekso Bionics have?

Ekso Bionics employs 67 workers across the globe.

What is Ekso Bionics' official website?

The official website for Ekso Bionics is www.eksobionics.com.

Where are Ekso Bionics' headquarters?

Ekso Bionics is headquartered at 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804.

How can I contact Ekso Bionics?

Ekso Bionics' mailing address is 1414 HARBOUR WAY SOUTH SUITE 1201, RICHMOND CA, 94804. The company can be reached via phone at 510-984-1761 or via email at [email protected]

This page was last updated on 2/28/2021 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.